Sanofi-Aventis Buys Licence for New Allergy Treatment – The Gazette (Montreal)

6 Sanofi Aventis buys licence for new allergy treatment   The Gazette (Montreal)
RichmondBizSense
 Sanofi Aventis buys licence for new allergy treatment   The Gazette (Montreal)
Sanofi-Aventis buys licence for new allergy treatment
The Gazette (Montreal)
Health Canada estimates around 600000 Canadians may be affected by life-threatening allergies, mirroring similar US statistics.
Local drug firm sells tech for $25 millionRichmondBizSense
Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel PR Newswire (press release)
Sanofi-Aventis Inks Licensing Deal With IntellijectTrading Markets (press release)
News-Medical.net -RTT News
all 39 news articles »


Comments are closed.